Sinofn Health
Sinofn Health
In the evolving landscape of global nutraceuticals, L-Glutamine stands as a cornerstone supplement. However, the market has pivoted significantly towards Fermented L-Glutamine, driven by consumer demand for purity, sustainability, and vegan compliance. At SINOFN Health, we leverage advanced microbial fermentation technologies, contrasting sharply with traditional synthetic (chemical synthesis) methods. Our process utilizes specific non-GMO bacterial strains to produce pharmaceutical-grade Glutamine, ensuring the absence of residual chemical solvents or animal-derived impurities. This aligns with E-E-A-T principles by providing verifiable data on purity profiles, essential for global clinical and sports nutrition brands.
Founded with the support of the Chinese Academy of Sciences, our research capabilities transcend typical OEM manufacturers, focusing on bioavailability and metabolic formulation.
Operating a massive 53,000㎡ facility, we manage the full lifecycle of Glutamine production, from raw material validation to finished powder blending.
We bridge the gap for global firms, holding ISO 22000, FSSC 22000, and HACCP certifications, ensuring our Chinese production meets EU/FDA standards for safety.
The application of L-Glutamine has expanded beyond simple muscle recovery. Current trends highlight its necessity in Gut-Brain Axis health, post-operative clinical nutrition (FSMP), and immune support formulations. SINOFN provides macro-solutions that enable global brands to create targeted product lines:
Mrs. GuoHong Liu, since 2012, has steered SINOFN with a "Profit with Purpose" philosophy. Our focus remains on bridging the gap in metabolic nutrition, translating high-end science into accessible products for global markets.
Led by Dr. Tan Shengjie (Peking University Medical) and Dr. Zhang Ying (CAS Postdoc), our team integrates international expertise, including our Dutch Chief Engineer, Hans van Dijk, ensuring our delivery technologies are globally competitive.
